Resources from the same session
617O - Lemzoparlimab, a differentiated anti-CD47 monoclonal antibody, in combination with azacitidine (AZA) in patients with newly diagnosed higher risk myelodysplastic syndrome (HR-MDS): Initial clinical results
Presenter: Chunkang Chang
Session: Proffered Paper session: Haematological malignancies
Resources:
Abstract
Slides
Webcast
Invited Discussant 617O
Presenter: Thomas Cluzeau
Session: Proffered Paper session: Haematological malignancies
Resources:
Slides
Webcast
618O - A phase I study of TRS005: An anti-CD20-MMAE antibody-drug conjugate, in relapsed or refractory b cell non-Hodgkin lymphoma
Presenter: Yuan-Kai Shi
Session: Proffered Paper session: Haematological malignancies
Resources:
Abstract
Slides
Webcast
619O - shRNA-mediated PD1 gene knock-down anti-CD19 CAR-T cell therapy for relapsed/refractory b cell malignancies
Presenter: Hong Cen
Session: Proffered Paper session: Haematological malignancies
Resources:
Abstract
Slides
Webcast
620O - CART-ddBCMA for multiple myeloma: Interim results from phase I study
Presenter: Matthew Frigault
Session: Proffered Paper session: Haematological malignancies
Resources:
Abstract
Slides
Webcast